<DOC>
	<DOCNO>NCT00507117</DOCNO>
	<brief_summary>Patients often difficulty sleep overnight sleep test lab environment . The purpose study determine take sleep aid improve sleep therefore quality sleep study .</brief_summary>
	<brief_title>Ezopiclone Improves Quality Overnight Polysomnography</brief_title>
	<detailed_description>The increase awareness sleep-disordered breathing ( i.e obstructive sleep apnea ) create grow demand polysomnography ( sleep study ) , result excessive wait time many laboratory . Sleep center therefore need develop method improve efficiency . Unfortunately many patient find difficult fall asleep unfamiliar environment laboratory setting ( `` first-night effect '' ) , circumstance may prolong fall alseep stay sleep . Likewise , intolerance continuous positive airway pressure ( CPAP ) may also reduce quality sleep study . Poor quality study may lead inability make diagnosis adequately titrate CPAP therapy . Unsatisfactory study may need repeat . Sleep aid ( hypnotic ) commonly use treat acute chronic insomnia . These agent minimal side-effects disrupt normal sleep architecture alter respiratory event . These attribute make agent ideal use improve quality sleep study enhance efficiency sleep center . In recent retrospective review , find use hypnotic prior sleep study result improved patient satisfaction improve quality sleep study significantly less study need repeat . Although promising , result must validate prospective , randomize , placebo-controlled trial . Eszopiclone ( Lunesta ) new non-narcotic , non-benzodiazepine hypnotic agent receive FDA approval December 15 , 2004 treatment acute chronic insomnia . Multiple clinical trial find eszopiclone decrease sleep latency , improve sleep efficiency/maintenance reduces wake time sleep onset ( WASO ) . Given efficacy promote sleep onset sleep maintenance excellent safety profile , agent ideal pre-study sedative . The purpose study validate use Lunesta improve quality overnight sleep study .</detailed_description>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<mesh_term>Eszopiclone</mesh_term>
	<criteria>All adult patient aged 1865 , evaluate sleep medicine provider Walter Reed Army Medical Center Sleep Disorders Clinic , refer PSG suspect Obstructive Sleep Apnea Syndrome Pregnancy Liver dysfunction history EtOH abuse Concomitant use benzodiazepine , narcotic ketozonazole Decompensated CHF CVA within 3 month Uncontrolled psychiatric disorder Patients &lt; 18 year old Patients 65</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>64 Years</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>Obstructive Sleep Apnea</keyword>
	<keyword>Polysomnography</keyword>
	<keyword>Non-benzodiazepine hypnotic</keyword>
</DOC>